The FDA has granted Orphan Drug Designation to Immune-Onc’s novel drug for chronic myelomonocytic leukemia (CMML), a rare form of blood cancer, marking a step forward in rare oncology. (August 28, 2024)
September 4, 2024
The FDA has granted Orphan Drug Designation to Immune-Onc’s novel drug for chronic myelomonocytic leukemia (CMML), a rare form of blood cancer, marking a step forward in rare oncology. (August 28, 2024)
Medico is a pharmaceutical and healthcare
products distribution company based in UAE
Quick Links
Special
© 2024 by NaqsTech Digital | All Rights Reserved | Powered by Medico.